BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17880565)

  • 1. Prolonged response times characterize cognitive performance in multiple sclerosis.
    Achiron A; Doniger GM; Harel Y; Appleboim-Gavish N; Lavie M; Simon ES
    Eur J Neurol; 2007 Oct; 14(10):1102-8. PubMed ID: 17880565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis.
    Ruet A; Deloire MS; Charré-Morin J; Hamel D; Brochet B
    Mult Scler; 2013 Oct; 19(12):1665-72. PubMed ID: 23459569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. fMRI investigation of disinhibition in cognitively impaired patients with multiple sclerosis.
    Smith AM; Walker LA; Freedman MS; DeMeulemeester C; Hogan MJ; Cameron I
    J Neurol Sci; 2009 Jun; 281(1-2):58-63. PubMed ID: 19344919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upper and lower extremity motor function and cognitive impairment in multiple sclerosis.
    Benedict RH; Holtzer R; Motl RW; Foley FW; Kaur S; Hojnacki D; Weinstock-Guttman B
    J Int Neuropsychol Soc; 2011 Jul; 17(4):643-53. PubMed ID: 21486517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting cognitive fatigue in multiple sclerosis: method matters.
    Walker LA; Berard JA; Berrigan LI; Rees LM; Freedman MS
    J Neurol Sci; 2012 May; 316(1-2):86-92. PubMed ID: 22336698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced information processing speed as primum movens for cognitive decline in MS.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Mult Scler; 2015 Jan; 21(1):83-91. PubMed ID: 25013149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of a multi-domain computerized cognitive assessment battery for patients with multiple sclerosis.
    Golan D; Wilken J; Doniger GM; Fratto T; Kane R; Srinivasan J; Zarif M; Bumstead B; Buhse M; Fafard L; Topalli I; Gudesblatt M
    Mult Scler Relat Disord; 2019 May; 30():154-162. PubMed ID: 30772674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive aging in patients with multiple sclerosis: a cross-sectional analysis of speeded processing.
    Bodling AM; Denney DR; Lynch SG
    Arch Clin Neuropsychol; 2009 Dec; 24(8):761-7. PubMed ID: 19820246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroop performance in multiple sclerosis: information processing, selective attention, or executive functioning?
    Macniven JA; Davis C; Ho MY; Bradshaw CM; Szabadi E; Constantinescu CS
    J Int Neuropsychol Soc; 2008 Sep; 14(5):805-14. PubMed ID: 18764975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficits in processing speed in patients with multiple sclerosis: evidence from explicit and covert measures.
    Denney DR; Gallagher KS; Lynch SG
    Arch Clin Neuropsychol; 2011 Mar; 26(2):110-9. PubMed ID: 21216726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisaccade performance in patients with multiple sclerosis.
    Fielding J; Kilpatrick T; Millist L; White O
    Cortex; 2009; 45(7):900-3. PubMed ID: 19327763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients.
    Wuerfel E; Weddige A; Hagmayer Y; Jacob R; Wedekind L; Stark W; Gärtner J
    PLoS One; 2018; 13(3):e0194873. PubMed ID: 29566099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and psychosocial features of childhood and juvenile MS.
    Amato MP; Goretti B; Ghezzi A; Lori S; Zipoli V; Portaccio E; Moiola L; Falautano M; De Caro MF; Lopez M; Patti F; Vecchio R; Pozzilli C; Bianchi V; Roscio M; Comi G; Trojano M;
    Neurology; 2008 May; 70(20):1891-7. PubMed ID: 18474844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue.
    Huolman S; Hämäläinen P; Vorobyev V; Ruutiainen J; Parkkola R; Laine T; Hämäläinen H
    Mult Scler; 2011 Nov; 17(11):1351-61. PubMed ID: 21846692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuropsychological tests in multiple sclerosis].
    Takeda A
    Nihon Rinsho; 2014 Nov; 72(11):1989-94. PubMed ID: 25518382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting cognitive dysfunction in a busy multiple sclerosis clinical setting: a computer generated approach.
    Lapshin H; Audet B; Feinstein A
    Eur J Neurol; 2014 Feb; 21(2):281-6. PubMed ID: 24200243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cognitive burden of multiple sclerosis in children.
    Banwell BL; Anderson PE
    Neurology; 2005 Mar; 64(5):891-4. PubMed ID: 15753431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.